Primary central nervous system lymphoma in Japan - A retrospective, co-operative study by CNS-Lymphoma Study Group in Japan

Journal of Neuro-Oncology

Volumn 19, Issue 3, 1994, Pages 197-215

  Hayakawa, Toru ^a   Takakura, Kintomo ^a   Abe, Hiroshi ^a   Yoshimoto, Takashi ^a   Tanaka, Ryuichi ^a   Sugita, Kenichiro ^a   Kikuchi, Haruhiko ^a   Uozumi, Tohru ^a   Hori, Tomokatsu ^a   Fukui, Hitoshi ^a   Ushio, Yukitaka ^a   Nomura, Kazuhiro ^a   Matsutani, Masao ^a   Mohri, Noboru ^a   Kumanishi, Toshiro ^a   Aozasa, Katsuyuki ^a   Nagashima, Kazuo ^a  

^a CNS Lymphoma Study Group in Japan ^*  (Japan)

Author keywords

brain tumor; CT; histopathology; non Hodgkin's lymphoma; primary CNS lymphoma; radiation therapy

Indexed keywords

ADULT; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOBLASTIC LYMPHADENOPATHY; IRRADIATION; JAPAN; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; ONSET AGE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMAN; INFANT; JAPAN; KARNOFSKY PERFORMANCE STATUS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0027965606     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/BF01053274     Document Type: Article

References (73)

1. Malignant lymphoma of the central nervous system in Japan: histologic and immunohistologic studies
2. Primary malignant lymphomas of the central nervous system in man
3. Primary intracranial malignant lymphomas with particular reference to their pathogenesis
4. Primary non-Hodgkin's lymphoma of the brain. A review
5. Malignant lymphomas of the nervous system
6. Non-Hodgkin's lymphoma in Osaka, Japan
7. Occurrence and prognosis of extranodal lymphomas
8. Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results in 12 cases
9. The Immunodeficiency Cancer Registry. A research resource
10. Occurrence of malignancy in immunodeficiency diseases. A literature review
11. Selective immunodeficiency and malignant lymphoma of the central nervous system. Possible relationship to the Epstein-Barr virus
12. Malignancies associated with immunosuppressive or cytotoxic therapy
13. The incidence of malignancies in transplant recipients
14. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome
15. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature
16. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature
17. Neurosurgical implications of the acquired immunodeficiency syndrome (AIDS)
18. Increasing incidence of primary brain lymphoma in the US
19. Immunohistochemical diagnosis of primary brain lymphoma using monoclonal antibodies: Confirmation of B-cell origin
20. Increasing incidence of CNS primary malignant lymphoma in southeast Scotland
21. The National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
22. Nonparametric estimation from incomplete observations
23. Regression models and life tables
24. Computed tomography in primary lymphoma of the brain
25. Computed tomography of malignant lymphoma of the brain
26. Radiographic findings in 32 cases of primary CNS lymphoma
27. Central nervous system lymphoma: Histologic types and CT appearance
28. Computed tomography of intracranial lymphoma
29. Response criteria for phase II studies of supratentorial malignant glioma
30. Radiation therapy in the management of primary malignant lymphoma of the brain
31. Primary non-Hodgkin's lymphomas of the CNS
32. Neoplasms of the reticuloendothelial system of the brain
33. Primary malignant lymphoma of the central nervous system
34. Primary malignant lymphomas of the central nervous system
35. Primary central nervous system lymphoma. A review
36. Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases
37. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival
38. Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature
39. Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective study
40. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma
41. Radiation therapy of microgliomas
42. The reticulum cell sarcoma-microglioma group of brain tumours. A consideration of their clinical features and therapy
43. Differential diagnostic aspects in malignant lymphomas involving the central nervous system
44. Radiation therapy in primary non-Hodgkin's lymphomas of the CNS
45. Radiation therapy for intracranial lymphoma
46. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy
47. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function
48. Two cases of intracerebral malignant lymphoma (Abstract in English)
49. Management results of primary intracranial malignant lymphoma (Abstract in English)
50. Cerebral lymphoma: clinical radiological correlation
51. Reticulosarcomas of the brain presenting as butterfly tumors. Possible implications for treatment
52. Biology of the human malignant lymphoma. Intracranial heterotransplantation in the nude athymic mouse
53. Primary malignant lymphoma of the brain. A clinicopathologic study of five cases
54. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford
55. Primary nonHodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases
56. Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain
57. Primary malignant lymphoma of the central nervous system. Report of Japan Lymphoma Radiation Therapy Group (JLRTG) (in Japanese)
58. Primary intracranial lymphomas
59. Primary lymphoma of the central nervous system
60. Primary lymphoma of the central nervous system
61. High dose methotrexate for non-AIDS primary central nervous system lymphoma, report of 13 cases
62. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone
63. Primary central nervous system lymphoma
64. A review of hyperosmotic blood-brain barrier disruption in seven experimental brain tumor models
65. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
66. The importance of dose intensity in chemotherapy of metastatic breast cancer
67. Adjuvant chemotherapy for primary lymphoma of the central nervous system
68. Treatment of central nervous system lymphoma with high dose methotrexate
69. Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate
70. Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system
71. Leukoencephalopathy following high-dose IV methotrexate chemotherapy with leucovorin rescue
72. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases